Cutting edge: anthrax lethal toxin inhibits activation of IFN-regulatory factor 3 by lipopolysaccharide
- PMID: 14707042
- DOI: 10.4049/jimmunol.172.2.747
Cutting edge: anthrax lethal toxin inhibits activation of IFN-regulatory factor 3 by lipopolysaccharide
Abstract
IFN-regulatory factor 3 (IRF3) is known to participate in the transcriptional induction of chemokines and cytokines, including IFNs, as a result of viral or bacterial infection. In this study, we demonstrate that the LPS-mediated activation of IRF3 and subsequent induction of chemokine genes or IRF3-responsive reporter constructs are inhibited after exposure of human or murine macrophages to the Bacillus anthracis toxin lethal factor. The inhibitory effect is caused by interference with the activation of the stress-activated protein kinase, p38, due to a proteolytic cleavage of mitogen-activated protein kinase kinase 6, and can be overcome by the ectopic expression of a cleavage-resistant mutant of mitogen-activated protein kinase kinase 6 or a constitutively active IRF3. The lethal factor-mediated inhibition of IRF3 activation and subsequent cytokine production through bacterial membrane components offers Bacillus anthracis an efficient mechanism to evade the innate immune response.
Similar articles
-
Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition.Science. 2002 Sep 20;297(5589):2048-51. doi: 10.1126/science.1073163. Epub 2002 Aug 29. Science. 2002. PMID: 12202685
-
Toxoplasma gondii interferes with lipopolysaccharide-induced mitogen-activated protein kinase activation by mechanisms distinct from endotoxin tolerance.J Immunol. 2004 Mar 1;172(5):3003-10. doi: 10.4049/jimmunol.172.5.3003. J Immunol. 2004. PMID: 14978104
-
Anthrax lethal factor-cleavage products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs.Biochem J. 2004 Mar 1;378(Pt 2):569-77. doi: 10.1042/BJ20031382. Biochem J. 2004. PMID: 14616089 Free PMC article.
-
Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha.FEBS Lett. 1999 Nov 26;462(1-2):199-204. doi: 10.1016/s0014-5793(99)01502-1. FEBS Lett. 1999. PMID: 10580119
-
Anthrax, MEK and cancer.Cell Cycle. 2002 Jan;1(1):10-5. Cell Cycle. 2002. PMID: 12429903 Review.
Cited by
-
Comparison of three anthrax toxin neutralization assays.Clin Vaccine Immunol. 2010 Jun;17(6):895-903. doi: 10.1128/CVI.00513-09. Epub 2010 Apr 7. Clin Vaccine Immunol. 2010. PMID: 20375243 Free PMC article.
-
Anthrax lethal toxin-mediated killing of human and murine dendritic cells impairs the adaptive immune response.PLoS Pathog. 2005 Oct;1(2):e19. doi: 10.1371/journal.ppat.0010019. Epub 2005 Oct 28. PLoS Pathog. 2005. PMID: 16254597 Free PMC article.
-
Anamnestic protective immunity to Bacillus anthracis is antibody mediated but independent of complement and Fc receptors.Infect Immun. 2008 May;76(5):2177-82. doi: 10.1128/IAI.00647-07. Epub 2008 Mar 3. Infect Immun. 2008. PMID: 18316379 Free PMC article.
-
Allelic variation on murine chromosome 11 modifies host inflammatory responses and resistance to Bacillus anthracis.PLoS Pathog. 2011 Dec;7(12):e1002469. doi: 10.1371/journal.ppat.1002469. Epub 2011 Dec 29. PLoS Pathog. 2011. PMID: 22241984 Free PMC article.
-
Analysis of defined combinations of monoclonal antibodies in anthrax toxin neutralization assays and their synergistic action.Clin Vaccine Immunol. 2012 May;19(5):731-9. doi: 10.1128/CVI.05714-11. Epub 2012 Mar 21. Clin Vaccine Immunol. 2012. PMID: 22441391 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous